Department of Surgical Oncology, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009, Marseille, France.
Department of Gastroenterology, Institut Paoli-Calmettes, Marseille, France.
Surg Endosc. 2024 Nov;38(11):6614-6624. doi: 10.1007/s00464-024-11232-9. Epub 2024 Sep 16.
Post-endoscopic duodenal perforation is a severe adverse event with high morbidity and mortality rates. Managing this rare event is challenging owing to limited clear guidelines. This retrospective study aimed to examine the relationship between time-to-treatment and morbidity among patients with post-endoscopic duodenal perforations.
Over 20 years, 78 consecutive patients with post-endoscopic duodenal perforations were analyzed. Among these, most patients underwent endoscopic procedures at the Paoli-Calmettes Institute, whereas some were referred from other centers after a diagnosis of perforation. We described the characteristics of patients who underwent medical treatment alone or interventional procedures. Among patients who underwent interventional management, we compared the outcomes following early or delayed procedures (later than 24 h post-duodenal perforation diagnosis).
Overall, 78 patients with post-endoscopic duodenal perforation were identified between September 2003 and September 2022. Of these, 17 (22%) patients underwent non-operative management, and 61 (78%) with peritonitis or adverse clinical features were treated with endoscopic or surgical procedures. Additionally, among these patients, 40 (65%) underwent immediate invasive procedures, surgically (n = 20) or endoscopically (n = 20). Patients with delayed procedures experienced more major Clavien-Dindo ≥ 3 complications and had an increase by 21 of the median comprehensive complication index. Overall, mortality occurred in 7 (8.9%) patients in the entire cohort and in 3 (14.3%) with delayed invasive procedures.
Delayed decision-making is a key factor complicating post-endoscopic duodenal perforation. Therefore, invasive procedures should be performed promptly in cases of adverse conditions requiring additional procedures, ideally within the first 24 h of perforation diagnosis.
内镜治疗后十二指肠穿孔是一种严重的不良事件,具有较高的发病率和死亡率。由于缺乏明确的指南,管理这种罕见的事件具有挑战性。本回顾性研究旨在研究内镜治疗后十二指肠穿孔患者的治疗时机与发病率之间的关系。
在 20 多年的时间里,分析了 78 例连续的内镜治疗后十二指肠穿孔患者。这些患者中,大多数在内科和创伤中心接受内镜治疗,而有些则是在穿孔诊断后从其他中心转来的。我们描述了仅接受药物治疗或介入治疗患者的特征。在接受介入治疗的患者中,我们比较了早期和晚期(内镜治疗后 24 小时后)手术的结局。
2003 年 9 月至 2022 年 9 月期间共发现 78 例内镜治疗后十二指肠穿孔患者。其中 17 例(22%)患者接受非手术治疗,61 例(78%)伴腹膜炎或不良临床特征的患者接受了内镜或手术治疗。此外,这些患者中有 40 例(65%)立即接受了有创治疗,包括手术(n=20)或内镜(n=20)。行延迟性有创治疗的患者发生更严重的 Clavien-Dindo 分级≥3 级并发症的风险增加 21%,综合并发症指数的中位数增加。在整个队列中,7 例(8.9%)患者死亡,3 例(14.3%)行延迟性有创治疗的患者死亡。
延迟决策是内镜治疗后十二指肠穿孔复杂化的关键因素。因此,在需要额外治疗的不良情况下,应尽快进行有创治疗,理想情况下在穿孔诊断后的 24 小时内进行。